Twitter

Link your Twitter Account to Market Wire News


When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.


Be alerted of any news about your stocks and see what other stocks are trending.



home / news releases / PRTC - PureTech Health pancreatic cancer antibody gets Orphan Drug designation


PRTC - PureTech Health pancreatic cancer antibody gets Orphan Drug designation

A monoclonal antibody under development from PureTech Health (PRTC) has been granted Orphan Drug status from the FDA for pancreatic cancer. The anti-galectin-9 candidate is in phase 1 of development. PureTech most advanced asset is LYT-100 (deupirfenidone), in phase 2 for long COVID respiratory complications and idiopathic pulmonary fibrosis.

For further details see:

PureTech Health pancreatic cancer antibody gets Orphan Drug designation
Stock Information

Company Name: PureTech Health plc
Stock Symbol: PRTC
Market: NASDAQ
Website: puretechhealth.com

Menu

PRTC PRTC Quote PRTC Short PRTC News PRTC Articles PRTC Message Board
Get PRTC Alerts

News, Short Squeeze, Breakout and More Instantly...